Repository logo
 

COVID-19 stokes inflammasomes.

Published version
Peer-reviewed

Type

Article

Change log

Authors

Abstract

The poor success rate of treating patients with aggressive sepsis in SARS-CoV-2 infections has highlighted again the challenges of managing systemic inflammatory conditions. In this issue of JEM, Rodrigues et al. (https://doi.org/10.1084/jem.20201707) discuss the role of inflammasome activation in COVID-19 disease severity, opening new possibilities for therapeutic management of sepsis syndromes.

Description

Keywords

COVID-19, Humans, Inflammasomes, SARS-CoV-2, Severity of Illness Index

Journal Title

J Exp Med

Conference Name

Journal ISSN

0022-1007
1540-9538

Volume Title

218

Publisher

Rockefeller University Press
Sponsorship
Wellcome Trust (108045/Z/15/Z)